Clonidine Hydrochloride Tablet, Extended Release
Product Images NDC 60687-462

6 FDA label images from American Health Packaging · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Clonidine Hydrochloride (NDC 60687-462). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp46121

Ahp46121
Clonidine hydrochloride 0.1 mg extended-release tablet, round and white with "CL" debossed on one side. The opposite side is plain with no markings. This oral tablet is manufactured by American Health Packaging.*
FDA Label Image

Figure 1 Mean Clonidine Concentration-time Profiles After Single Dose Administration (Figure 1)

Figure 1 Mean Clonidine Concentration-time Profiles After Single Dose Administration (Figure 1)
A line graph depicting mean concentration (pg/mL) of Clonidine Hydrochloride over time (hours). It compares extended-release (fasted and fed conditions) and immediate-release (fasted) formulations, showing concentration changes from 0 to 48 hours post-dose.*
FDA Label Image

Figure 2: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Treatment Failure (study 3) (Figure 2)

Figure 2: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Treatment Failure (study 3) (Figure 2)
A Kaplan-Meier curve graph showing the estimated proportion of patients with treatment failure over days from randomization, comparing Clonidine Hydrochloride Extended-Release tablets and placebo. The y-axis represents the estimated proportion of treatment failure, and the x-axis shows days up to approximately 220. The graph includes censored data points for both treatments.*
FDA Label Image

Structural Formula (Clonidine)

Structural Formula (Clonidine)
Chemical structure of Clonidine hydrochloride showing its molecular composition including chlorine atoms and heterocyclic rings.*
FDA Label Image

Image 01

Image 01
Label for Clonidine Hydrochloride Extended-Release Tablets, 0.1 mg strength, containing 30 tablets (3 blister cards of 10 each). The label includes dosage form, strength, NDC 60687-462-21, and manufacturer information for American Health Packaging. It states prescription-only status and storage instructions.*
FDA Label Image

Image 02

Image 02
Labels for Clonidine hydrochloride Extended-Release Tablets, 0.1 mg strength, distributed by American Health Packaging. Each label includes the product name, dosage form, strength, a barcode, Lot and Expiry placeholders, and mentions the labeling company in Columbus, Ohio.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.